Building on the remarkable success of The Business Show Asia 2024, we are delighted to announce its prestigious return to Singapore. Join us on the 27th and 28th of August as Asia’s foremost business event unfolds at the world-class Sands Expo & Convention Centre, Marina Bay Sands.
Following a highly successful 2024 edition at the Sands Expo, where over 8,000 business leaders gathered to connect, learn and grow, we are proud to return with this distinguished event once again. The Business Show Asia will continue to serve as a premier platform for entrepreneurs, startups and established professionals to access the insights, resources and inspiration needed to launch, scale and thrive in today’s competitive landscape.
What to Expect at The Business Show Asia 2025:
1. Inspiring Keynote Speakers The Business Show Asia 2025 will feature an exceptional lineup of visionary keynote speakers and industry leaders. Attendees will gain valuable insights on entrepreneurship, innovation, digital transformation, leadership and more, delivered by some of the most influential voices in business.
2. Strategic and Practical Masterclasses Our agenda includes a series of interactive masterclasses led by experienced professionals. These sessions will cover essential topics such as scaling a startup, financial planning and business growth, providing attendees with practical strategies they can apply right away.
3. Innovative Exhibitor Showcase The exhibition hall will host over 250 top-tier exhibitors showcasing the latest in business technology, marketing tools and operational solutions. It is the ideal space to discover products and services that help businesses operate more efficiently and competitively.
4. Valuable Networking Opportunities The Business Show Asia goes beyond learning by fostering meaningful connections. With dedicated networking zones and Speed Networking sessions, attendees can meet potential partners, clients, mentors and collaborators who can help elevate their business journey.
Riding the Wave of Success: Highlights from 2024
The 2024 edition of The Business Show Asia was an outstanding success. From the vibrant atmosphere across the exhibition floor to impactful keynotes delivered by leaders from Google, Microsoft, and PayPal, the event became a launchpad for new ideas and transformative growth. Attendees immersed themselves in expert-led masterclasses on business expansion, digital transformation, and leadership. Countless professionals walked away with valuable insights and connections that proved essential to their business journey.
The Future Starts Here: Asia 2025
The Business Show Asia 2025 is set to return bigger, bolder, and more influential. Whether you are an aspiring entrepreneur or an established executive, this event offers a powerful platform to unlock strategies, explore innovations, and build meaningful partnerships. With engaging seminars, hands-on masterclasses, top-tier exhibitors, and endless networking potential, this is the ultimate destination for anyone serious about scaling their business.
Mark Your Calendar
Join us on 27 and 28 August 2025 at the Sands Expo & Convention Centre in Singapore for two inspiring days of learning, innovation, and connection.
Registration is now open, so secure your spot and get ready to be part of Asia’s leading business event. We look forward to welcoming you.
Tickets are free to attend! Click here to register.
About The Business Show
Business Show Media is the global event organizer behind The Business Show series celebrating over 25 years of empowering entrepreneurs, SMEs, and startups around the world. With a proven track record of producing more than 44 editions across cities including London, Miami, Las Vegas, Australia, and Asia.
As Asia’s leading business event, The Business Show Asia brings together thousands of business owners and founders in Singapore. It offers access to cutting-edge tools, industry-leading speakers, masterclasses, and networking opportunities making it the region’s must-attend growth event.
– Robust visitor turnout despite downpour; special offers and theme days to spark shopping excitement
Organised by the Hong Kong Trade Development Council (HKTDC), the five-day (14-18 August) Food Expo, Beauty & Wellness Expo and Home Delights Expo open to the public from today at the Hong Kong Convention and Exhibition Centre. The Food Expo PRO, held concurrently from 14 to 16 August, is open to trade buyers for the first two days and to the public and trade buyers on the final day. For the first time, the Hong Kong International Tea Fair will be open to both industry professionals and the public throughout its three-day duration (14-16 August). The International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM), organised by the Modernized Chinese Medicine International Association (MCMIA) together with the HKTDC and ten scientific research institutions, also take place today and tomorrow (14-15 August).
Due to Black Rainstorm Warning Signal, the opening of the fairs was delayed and the first session of the International Conference of the Modernization of Chinese Medicine was livestreamed.
The Food Expo, Beauty & Wellness Expo, Home Delights Expo will extend the opening hours to 11pm on 15-17 August. The Food Expo PRO and Hong Kong International Tea Fair will remain open until 6pm today and tomorrow (14 to 15 August) and until 5pm on Saturday (16 August).
Margaret Fong, Executive Director of the HKTDC, stated: “The 35th Food Expo celebrates an important milestone this year. The five-in-one mega event plays host to some 1,890 exhibitors from 36 countries and regions, serving as a one-stop destination and a vibrant marketplace for both trade professionals and consumers, where gourmet foods, fine teas, home essentials and beauty products can be found. Meanwhile, Food Expo PRO is dedicated to boosting Hong Kong’s status as a premier business hub for the food industry, not just in Mainland China, but across Asia and the globe. It empowers F&B professionals to explore new opportunities, forge valuable connections, and drive innovation.”
Several exhibitors expressed that their special offers will remain unchanged. Among them, Phelix Pun from Ng Fung Hong Limited shared that staff arrived as usual this morning to prepare for the exhibition. They hope that, once the exhibition opens, it will continue to boost their business, with the planned special offers and interactive games proceeding as scheduled. They believe that citizens will continue to turn out enthusiastically to visit and shop.
Five themed days create a quality living space 1. Shall We Tea’ (14 August) Today’s focus is on the variety of Chinese and Western tea beverages. This year, the Hong Kong International Tea Fair opens to the public for all three days for the first time, featuring pavilions from countries and regions such as Fujian, Hubei, Zhejiang, Kenya, and Sri Lanka to promote tea culture. Visitors can sample premium traditional teas like Bai Hao Yin Zhen (Silver Needle tea) (Booth: 5F-F01), one of the finest Chinese white teas, alongside wellness capsule tea (Booth: 5F-F05), and innovative new-style tea beverages from various regions (Booth: 5G-A21). The “Friends of Tea” Zone also offers tea-pairing snacks, tea-infused perfumes and more, offering a blend of traditional and modern tea culture experiences. Visitors can participate in various talks, including “The Legacy and Contemporary Dialogues of Chinese Tea Culture” and “The Beauty of Tea, Where Small Things Reveal Greatness”, as well as activities led by certified water sommeliers and tea masters exploring the diversity of water, decoding the secrets of tea flavours, and delving into the joy of tea appreciation.
At the Food Expo, visitors can enjoy premium matcha and hojicha from Kyoto’s century-old Marukyu Koyamaen tea garden, blended with locally made fresh nut butter to create tea-flavoured gelato (Booth: 3B-E10). The Nin Jiom Tea Pairing Lucky Bag (Booth: 1C-A10) includes five functional teas with various health benefits. Additionally, Earl Grey tea infused with bergamot in drip-filter bags (Booth: 1D-A12) offers a refreshing citrus aroma.
2. Flavours of Intangible Cultural Heritage (15 August) Despite its small size, Hong Kong boasts over 50 items on its intangible cultural heritage list related to food, showcasing its unique culinary culture. Exhibitors will present tea bags made with 100% Ceylon black tea, ready to brew for an effortless Hong Kong-style milk tea or Yuan Yang (Booth: 5F-F21). Additionally, there’s handmade shrimp paste from Hong Kong’s last remaining licensed salted fish and shrimp paste factory, capturing the authentic flavours of Hong Kong’s fishing village heritage (Booth: 1A-E02).
The themed day features a series of activities centered on intangible cultural heritage. At the Home Delights Expo, master artisan Choi Wing-kei will share the story of preserving the traditional craft of floral plaque making, alongside demonstrations of Taiji and Wing Chun martial arts techniques, as well as introductions to the cultural significance of bamboo steamers and bamboo craftsmanship. The Food Expo will showcase demonstrations of making traditional Hakka Sau Fan. The Hong Kong International Tea Fair will host a seminar on “Chiu Chow Kung Fu Tea,” exploring the distinctive tea culture of the Chaoshan region.
3. Asian Delights (16 August) The day celebrates Asian cuisine and culture, featuring cooking demonstrations of Vietnamese dishes and molecular Thai cuisine, complemented by performances of the traditional Japanese shamisen, K-Pop dance, and a Thai yoga massage experience at the Beauty & Wellness Theatre, immerses visitors in the vibrant essence of Asia.
At the Food Expo, the China National Agricultural Pavilion, organised by the Agricultural Trade Promotion Centre, the Ministry of Agriculture and Rural Affairs of Mainland China, will present a thousand agricultural and food products from 13 provinces, such as Korla fragrant pears, Xinjiang safflower seed oil, rainbow trout salmon, Guangdong lychee black tea, Lianzhou mustard greens, Hainan Wuzhishan large-leaf tea, Northeast black soil organic rice, and Yantai apples from the Qilu region.
Visitors can explore a range of premium products at the Food Expo PRO. The 100% natural, hand-picked wild pine nut oil from Mongolia (Booth: 5C-G20) is a healthy choice for daily diets. A whisky from Soni Village in Nara Prefecture, renowned for its pristine spring water (Booth: 5B-B06), its smooth taste is perfect for a variety of uses, whether drinking neat, on the rocks, or mixed into a variety of cocktails. The spicy and crispy milk chocolate, made with Sichuan pepper oil, Espelette pepper, and almond paste filling (Booth: 3B-E04), would offer an unforgettable tasting experience.
4. Body, Mind, and Soul (17 August) This year, the Beauty & Wellness Expo introduces the new “Scentsation”Zone, featuring over 20 brands showcasing a range of perfumes and aromatherapy products to nurture both mind and body. Making its debut at the expo, Lush (Booth: 3E-D08) presents its popular Deep Sleep Magnesium Massage Bar, designed to enhance sleep quality. In response to the growing opportunities in the silver economy, exhibitors are offering various products and services tailored for seniors. Mannings, participating in the Beauty & Wellness Expo for the first time, will feature a Smart Health Station, offering free health tests to help seniors select the best fit wellness products.
The Food Expo, Beauty & Wellness Expo, and Home Delights Expo will host a series of seminars and activities, including hand massage workshops, discussions on the emerging trend of Hong Kong residents seeking cross-border medical care, towel exercise sessions, explorations of ergonomics and the latest treatments for various diseases, and diets to boost immunity. The performance stage will feature various sports demonstrations, such as taekwondo, street dance, and ballroom dancing.
5. Taste HK (18 August) In recent years, organic farming has gained popularity, with growing demand for local produce. A cooking demonstration, co-organised by DRAGONS’ DEN, the Vegetable Marketing Organization, and the Fish Marketing Organization at the Food Expo, will use local ingredients to create healthy and delicious home-cooked dishes. Additionally, the Home Delights Expo will feature notable products, including a glass-lined insulated handheld cup that won the 2024 Red Dot Product Design Award (Booth: 3F-D20), a water faucet awarded the 2023 Red Dot Design Award (Booth: 3F-B18), and a plug-and-play portable air conditioner that requires no exhaust duct (Booth: 3F-E25).
At the Food Expo, visitors can savour a sparkling soda infused with lemon honey, salted plum, and ginger (Booth: 3B-A07), recreating classic Hong Kong flavors. A Kee Wah snack set paired with a cute panda backpack (Booth: 1E-C02) combines iconic treats. At the Food Expo PRO, traditional mooncakes developed by the Hong Kong Polytechnic University’s food team (Booth: 5C-C17) utilise exclusive AkkMore™ fungal fat-replacement technology, blending health with deliciousness.
Exploring Halal Products, Coffee, and Food Science Opportunities The 3rd Food Expo PRO and the 35th Food Expo have introduced a Halal food and beverage label since last year to assist exhibitors in expanding into the halal product market. This year, the two expos feature over 120 food suppliers showcasing halal products from around the world, a 20% increase compared to last year. The expo also strengthens collaborations with countries with thriving halal food markets. Group pavilions at the Food Expo PRO include ASEAN countries such as the Philippines, Thailand and Vietnam, enriching the variety of halal exhibits.
The Food Expo PRO introduces a new “Coffee Zone” this year, showcasing coffee products, accessories, and machines from various origins. Yunnan Province, China’s leading coffee bean producer, is represented by several Pu’er City companies exhibiting Kunlu Mountain and Jinpaoshan roasted beans and other products. Another highlight, the “Food Science and Technology Zone”, presents alternative and future foods of interest to industry professionals. Today’s Food Tech Symposium explores the development of additive-free foods and clean labeling in Hong Kong. Exhibitors are also targeting the silver economy, showcasing innovative products such as soft-textured mooncakes and cognitive health supplements developed by local exhibitors.
21 Prominent Speakers Discuss the Latest Developments in Chinese Medicine(14-15 August) The Modernized Chinese Medicine International Association, together with the HKTDC and ten scientific research institutions, provides industry professionals with the latest insights into Chinese medicine. Themed “The Latest Research Progress in the Prevention and Treatment of Tumors, Inflammation, and Cardiovascular and Cerebrovascular Diseases with Traditional Medicine”, the conference secures 21 prominent speakers, including experts from Hong Kong, Mainland China, and overseas, sharing innovative achievements and trends in the globalisation of Chinese medicine. Conducted in a hybrid format, the conference offers broader opportunities for interaction with speakers. Hong Kong-registered Chinese medicine practitioners can also earn Continuing Medical Education credits by attending the conference.
Food Expo Celebrates 35th Edition with Exclusive Offers To celebrate the 35th Food Expo, free admission tickets are available each day before noon, with 350 each at Halls 3FG and 5FG entrances and redeemable with the designated advertisement. Over 100 promotions are priced at HK$35 or discounted by 65% to tie in with the 35th Food Expo. The “Food Expo 35th Edition – Treasure Hunt” game engages visitors in Hall 3, where they can hunt for ‘treasure’, scan QR codes, answer questions correctly, and redeem gifts. Together with daily lucky draws, prizes are worth over HK$1 million, including kitchenware, furniture, beauty products, gourmet foods, health items; a lucky draw entry is granted for a single transaction of HK$300 or more. The “Smart Bidding” session allows visitors to bid on favourite items starting at 10% of their original price. Visit the “August Happy Buy” promotional website for flash sales and exclusive discounts.
Snoopy is celebrating its 75th anniversary this year. The organiser invites visitors to participate in the “Snoopy Hide & Seek” activity at the Home Delights Expo, where they can snap photos with Snoopy and friends for a chance to win special prizes, joining in the festive celebration.
Physical ticket sales are unavailable at the venue. E-tickets can be purchased in advance through AlipayHK, Alipay, 01 Space, 7-Eleven, Circle K, Octopus app, or The Club app, or at venue entrances using AlipayHK, Alipay, or Octopus. Discounted “Morning Admission” and “Evening Admission” are offered on select dates.
About HKTDC The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong’s trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels.
The 74th China (Linyi) International Hardware Expo, one of Asia’s most established industry gatherings with a history dating back to 1952, is set to take place from September 5–7, 2025 at the Linyi International Exhibition Center in Shandong, China. Hosted by the China Hardware, Electrical Equipment, and Chemicals Association, the event will bring together over 1,700 manufacturers and showcase more than 150,000 products across the hardware, tools, machinery, and building solutions sectors.
Recognized as China’s largest hardware production and logistics hub, Linyi will welcome global buyers to engage directly with factories producing a wide range of products, including hand and power tools, woodworking equipment, welding systems, abrasives, fasteners, protective gear, LED lighting, plumbing, sanitary ware, and decorative materials.
The expo offers multiple advantages for international participants, such as factory-direct sourcing with competitive pricing, customizable orders, and quality assurance. Organizers will provide free accommodation, flights, and meals for qualified overseas buyers, along with B2B matchmaking services, on-site order processing, and logistical support. Additional benefits include language interpretation, guided factory tours, and assistance with export procedures.
Beyond the exhibition hall, attendees can explore the Linyi Hardware Market—Asia’s largest permanent trade center—for bulk negotiations and production line inspections, further strengthening opportunities for global collaboration in the hardware industry.
Everest Medicines (HKG: 1952.HK, Everest) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Application (NDA) for VELSIPITY(R) (etrasimod) for the treatment of patients with moderately to severely active ulcerative colitis (UC).
Building on prior approvals in Singapore, Hong Kong SAR, and Macao SAR, as well as NDA acceptance in South Korea, this marks significant progress in the commercialization of VELSIPITY(R) across Asia. In December 2024, China’s National Medical Products Administration (NMPA) officially accepted the NDA for VELSIPITY(R).
As a next-generation selective S1P receptor modulator, once-daily oral etrasimod demonstrates robust efficacy across multiple endpoints, including clinical remission, mucosal healing, endoscopic normalization and histological remission. Its clinical value has been robustly demonstrated in multiple global Phase III studies, including ELEVATE UC 52, ELEVATE UC 12 and ENLIGHT (ES101002) studies.
“The NDA acceptance for VELSIPITY(R) in Taiwan, China marks another key progress in our commercialization pathway across Asia. As the number of UC patients in Asia continues to rise, there remains a significant unmet medical need. In China alone, there were approximately 800,000 patients with UC in 2024, and the number is estimated to reach 1 million by 2030. UC patients face the dual challenges of long-term treatment and maintaining quality of life.” said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “This NDA acceptance underscores the clinical value of VELSIPITY(R). We remain committed to accelerating access to this innovative therapy in Mainland China and other Asian markets, supporting long-term disease management while enhancing patients’ quality of life.”
The clinical part submitted to TFDA is mainly based on results from the ELEVATE UC Phase 3 registrational program (ELEVATE UC 52 and ELEVATE UC 12) and the ENLIGHT study (ES101002). The ELEVATE UC Phase 3 registrational program evaluated the safety and efficacy of etrasimod 2 mg once-daily on clinical remission in UC patients with moderately to severely active UC who had previously failed or were intolerant to at least one conventional, biologic, or Janus kinase (JAK) inhibitor therapy. Both studies achieved all primary and key secondary efficacy endpoints, with a favorable safety profile consistent with previous studies of etrasimod.
The ENLIGHT study (ES101002) conducted by Everest, is a multicenter, randomized, double-blind and placebo-controlled Phase 3 trial of etrasimod in Asian countries, including China Mainland, China Taiwan and South Korea. This is the largest Phase 3 trial of moderately to severely active ulcerative colitis in Asia completed to date, with 340 eligible subjects randomized to treatment with etrasimod or placebo. The results demonstrate that treatment with etrasimod 2 mg resulted in a clinically meaningful and statistically significant improvement in the primary and all secondary endpoints. These findings provide strong evidence supporting the use of etrasimod in adult Asian patients with moderately to severely active ulcerative colitis.
As Everest’s third commercialized product, VELSIPITY(R) has been officially approved by the Guangdong Provincial Medical Products Administration for adult patients with moderately to severely active UC. It is now available at medical institutions designated under the Connect Policy in the Greater Bay Area. Additionally, Everest has launched a factory construction project at its Jiashan site to support local production of VELSIPITY(R).
Comprehensive updates improve asset protection, governance, and dispute resolution mechanisms
Ras Al Khaimah International Corporate Centre (RAK ICC) has announced significant amendments to its Foundations Regulations 2019, which took effect on 31 July 2025. The changes represent one of the most substantial updates to the regime since its introduction, reinforcing the UAE’s position as a competitive jurisdiction for wealth structuring and long-term asset protection.
RAK ICC Foundations are widely recognized for their flexibility, confidentiality, and legal robustness, making them a preferred choice for high-net-worth individuals, entrepreneurs, and family offices, both within the UAE and internationally. These structures are commonly used for succession planning, family governance, and consolidating diverse assets under a single legal entity.
The 2025 amendments introduce stronger legal safeguards and improved governance measures which include:
Firewall Provisions – Stronger protection from foreign judgments conflicting with RAK ICC Regulations.
Three-Year Statute of Limitations – Limits challenges to establishment or asset transfers to three years.
Cause of Action Provisions – Creditor fraud claims are limited to the specific asset involved and only if rendering the founder insolvent.
Duress and Officer Protections – Nullifies actions taken under foreign legal coercion, preserving internal governance autonomy of a foundation.
Strengthened Arbitration Framework – Disputes can be resolved privately with court-level powers.
Private Trustee Foundation Provisions – Clarifies asset segregation and fiduciary integrity for property held in trust by a foundation.
Assets held within RAK ICC Foundation will now benefit from enhanced firewall provisions, ensuring that foreign judgments conflicting with UAE law cannot be enforced against them. A new three-year limitation period has been established for challenging the formation of a foundation or the transfer of assets into it, providing greater certainty for founders and beneficiaries. The reforms also tighten creditor protection rules by requiring proof of insolvency in fraudulent transfer claims, with liability capped at the value of the disputed asset to prevent overreach into unrelated holdings.
In addition, the updated regulations address governance integrity and operational resilience. Officers of a foundation who receive foreign orders inconsistent with RAK ICC law are obligated to disregard them, thereby safeguarding the autonomy of the foundation’s decision-making. The framework now explicitly confirms that assets held in trust by a foundation are legally distinct and separate from foundation property, ensuring clear asset segregation. Dispute resolution has also been strengthened, with arbitration provisions expanded to grant tribunals court-like powers, enabling disputes to be resolved efficiently, confidentially, and in line with international best practices.
These changes are part of RAK ICC’s broader strategy to maintain a forward-looking legal and regulatory environment that meets global standards while catering to the specific needs of its client base. They reflect the jurisdiction’s commitment to supporting sophisticated wealth planning strategies that balance control, privacy, and long-term security.
By enhancing its Foundations regime, RAK ICC is cementing its position in the UAE as a trusted partner for those seeking secure, adaptable, and internationally compliant solutions for wealth preservation and intergenerational planning.
About RAK ICC Ras Al Khaimah International Corporate Centre (RAK ICC) is a corporate registry based in Ras Al Khaimah, United Arab Emirates. The organisation provides international business companies and foundations, typically used for private and business structuring, asset consolidation, and succession planning. To date, RAK ICC has incorporated thousands of international companies and supports multi-billion dirhams in structured assets. It serves high-net-worth individuals, entrepreneurs, and businesses seeking flexible and secure solutions for long-term business and wealth management.
Following the lifting of the Black Rainstorm Warning Signal at 11:10am, the Food Expo, Beauty & Wellness Expo, Home Delights Expo, Food Expo PRO and Hong Kong International Tea Fair will reopen at 1:10pm.
The Food Expo, Beauty & Wellness Expo, Home Delights Expo will be extended and close at 11pm from 15 August to 17 August, allowing public visitors to enjoy shopping in these fairs—with a single ticket. The Food Expo PRO and Hong Kong International Tea Fair will remain open until 6pm today and tomorrow (14 to 15 August) and until 5pm on Saturday (16 August), enabling trade buyers and exhibitors to continue their business discussions.
Admission tickets valid for today may be used for entry on any of the remaining fair days.
Sessions 2 and 3 of the International Conference of the Modernization of Chinese Medicine afternoon programme will be resumed in a hybrid format.
Media enquiries Ogilvy Public Relations: Rex Cheuk +852 5618 9908 rex.cheuk@ogilvy.com
About HKTDC The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong’s trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels.
As the Black Rainstorm Warning Signal was issued at 7:50am, the opening of Food Expo, and the concurrent Food Expo PRO, Hong Kong International Tea Fair, Beauty & Wellness Expo and Home Delights Expo, will be postponed. The opening ceremony originally scheduled for 10:30am, is cancelled. The International Conference of the Modernization of Chinese Medicine will be accessible via livestream.
The organiser will make appropriate arrangements to ensure the safety of those already at the venue and will closely monitor the weather conditions. The organiser will open the Food Expo, Food Expo PRO, Hong Kong International Tea Fair, Beauty & Wellness Expo and Home Delights Expo two hours after the Black Rainstorm Warning Signal is cancelled.
About HKTDC The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong’s trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn
FWD Group Holdings Limited(FWD Group or FWD) today marked its 12th anniversary by announcing 12 charitable grants dedicated to supporting local communities across Asia.
Since its founding in 2013, FWD has grown from its beginnings in Hong Kong SAR, Macau SAR, and Thailand to now span 10 markets across Asia, including Cambodia, Indonesia, Japan, Malaysia, the Philippines, Singapore, Vietnam.
The 12 grants are focused on supporting non-government organisations (NGOs) with initiatives spanning financial literacy, social entrepreneurship, career readiness, and health and wellbeing in communities.
Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “Celebrating our 12th anniversary as a newly listed company makes this milestone especially meaningful. The life insurance business is a deeply personal one, with FWD now touching the lives of 30 million people and their families across Asia. With caring as one of our core values at FWD, giving back in tangible and impactful ways to the wider community is a big part of our vision of changing the way people feel about insurance.”
Earlier this year, FWD extended its regional partnership with JA (Junior Achievement) Worldwide – a youth-focused charity and Nobel Peace Prize 2025 nominee – to reach 40,000 more students across Asia by the end of 2027 with its award-winning financial literacy programme. In the next phase, the programme aims to integrate new tools to strengthen financial literacy, mental wellness, and resilience – while involving more teachers and families in the process.
The 12 NGO grants include: – Cambodia: Partnering with Cambodia Children’s Fund to launch the “Let’s Save Debate,” a university-level initiative promoting financial literacy through debate and research.
– Hong Kong SAR: Expanding the JA SparktheDream programme with Junior Achievement Hong Kong and introducing the JA SparktheDream Wellness Workshop that blends financial education with social and emotional learning to engage primary school students.
Supporting WISE (Women In Sports Empowered Hong Kong Limited) with its programme to empower teenage girls through sports for mental wellbeing and self-confidence.
– Indonesia: Supporting InnovateHer Academy 3.0 with KUMPUL.ID to equip female entrepreneurs with business skills, mentorship, and investment readiness skills.
Launching a new financial education programme with Prestasi Junior Indonesia on the back of the best practices from the JA SparktheDream programme. The new programme will equip 30 school teachers with the skills and knowledge to deliver engaging and effective financial literacy lessons.
– Japan: Partnering with the National Welfare Beauty and Barber Training Association to provide medical wigs and support for cancer patients during Breast Cancer Awareness month.
– Malaysia: Launching the Bijak Ibu Jaga Anak & Kewangan (B.I.J.A.K.) programme with GivingHub to provide 200 low-income families with health and financial literacy educational workshops as well as 200 health screenings and consultations.
– Philippines: Collaborating with Junior Achievement Philippines on JA Forward Your Success to support graduating college students with financial literacy and career planning.
– Singapore: Supporting Club Rainbow (Singapore) in helping children with chronic illnesses and their families by joining Ride & Ralk for Rainbows 2025, along with a visit to Mandai Wildlife Reserve for children and youths with rare genetic and neurological disorders.
– Thailand: Sponsoring seven hospitality scholarships via Pimali Foundation for disadvantaged youth, helping them build sustainable careers.
Expanding the JA SparktheDream programme with Junior Achievement Thailand by training 30 teachers in financial literacy to deepen their financial management skills and better support students.
– Vietnam: Supporting Be A Finnovator with the Startup Vietnam Foundation on a training and debate competition for university students to build financial leadership, critical thinking, and responsible money habits.
About FWD Group FWD Group is a pan-Asian life and health insurance business that serves approximately 30 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 1828. For more information, please visit www.fwd.com
Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) (“Focus” or the “Company“), a leading Canadian graphite developer advancing high-grade projects in Québec, is pleased to announce the resumption of work on the Environmental and Social Impact Assessment (“ESIA“) for its 100%-owned Lac Knife flake graphite project located near Fermont, in the province’s prolific iron ore mining district.
The Company has formally re-engaged IOS Geosciences Inc. (“IOS“), a leading Québec-based geological consulting firm and former general contractor on the ESIA, to complete a total of sixteen (16) technical reports required for submission to Québec’s environmental and natural resource authorities. These reports represent a major step in advancing the Lac Knife project toward permitting and the goal of mine construction.
The ESIA program, initially launched in 2020, involves multidisciplinary technical evaluations and environmental baseline work conducted across 2020 and 2021. Finalization was delayed due to funding constraints but is now back on track. Report completion is estimated by early 2026, with submissions planned shortly thereafter to the Québec Ministry of Sustainable Development, Environment, and the Fight Against Climate Change (“MDDELCC“), as well as the Ministry of Natural Resources and Forests (“MRNF“).
The sixteen (16) technical reports in progress cover critical permitting areas, including:
Condemnation and pit wall drilling
Acid-generating potential analysis
Geotechnical drilling and soil mechanics
Soil geochemistry and chemistry baseline
Lake-bottom geochemical and surface water quality surveys
Groundwater habitat assessment and follow-up
Caribou habitat assessment and follow-up
Geometallurgical and graphite flake characterization
These comprehensive studies are essential for satisfying Québec’s rigorous environmental and social licensing requirements and underscore Focus Graphite’s commitment to environmental stewardship and Indigenous engagement through project development.
In parallel, Focus has also authorized IOS proceed with geochemical analysis of over 1,000 split and pulverized drill core samples collected from its 2022 exploration drilling program at the Lac Tétépisca (“Tétépisca“) graphite project. The samples, targeting the Southwest MOGC and West Limb geophysical (MAG-EM) conductors, will undergo carbon and sulfur determinations at certified laboratories.
Upon receipt of assays, IOS will finalize and submit the corresponding technical reports covering 14,900.5 metres of core drilling from 74 holes to the MRNF. An updated Canadian Institute of Mining, Metallurgy and Petroleum (“CIM“) and National Instrument (“NI“) 43-101 compliant Mineral Resource Estimate (“MRE“) for the Manicouagan-Ouest Graphitic Corridor (“MOGC“) graphite deposit is anticipated in Fall 2025, which will further define Tétépisca’s development potential alongside Lac Knife.
“Resuming the ESIA is a pivotal milestone that moves us closer to full permitting and our goal of mine development at Lac Knife,” said Dean Hanisch, CEO of Focus Graphite. “With most fieldwork and laboratory studies already complete, we’re in a strong position to finalize this critical stage efficiently. At the same time, initiating assay work at Tétépisca to support an upgraded mineral resource estimate reflects our commitment to building value across our entire Québec asset base.”
The Company also announced the grant of incentive stock options as compensation to its directors, officers, employees, and consultants. Options to purchase up to 4,215,000 Common Shares of the Company have been granted at an exercise price of $0.14 per share. The options expire on 13 August, 2030. Additionally, the Company has granted 1,350,000 restricted stock units (“RSUs”) to officers, directors, and consultants of the Company under the terms of the Company’s restricted share unit and equity incentive plan (the “RSU and EIP Plan”). Each RSU entitles the holder to acquire one common share of the Company after the vesting period in accordance with the Plan.
Qualified Persons
The technical content disclosed in this news release was reviewed and approved by Réjean Girard, P.Geo. (QC), President of IOS Geosciences Inc., a consultant to the Company, and a qualified person as defined under National Instrument NI-43-101.
About Focus Graphite Advanced Materials Inc.
Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.
Our Lac Tétépisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining – we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.
Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals – reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could,” “intend,” “expect,” “believe,” “will,” “projected,” “estimated,” and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company’s current beliefs or assumptions as to the outcome and timing of such future events.
In particular, this press release contains forward-looking information regarding, among other things, the completion and submission of the sixteen technical reports required for the Lac Knife Environmental and Social Impact Assessment, the anticipated timeline for ESIA report submission and permitting, the initiation and results of geochemical analyses at the Lac Tétépisca project, the anticipated updated NI 43-101 Mineral Resource Estimate for the Tétépisca deposit, the Company’s positioning as a near- and long-term secure supplier of specialty graphite materials, and the potential geopolitical significance of Canadian graphite supply.
Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company’s public disclosure documents available under its profile on SEDAR+.
The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.
Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.
Essex Bio-Technology Limited (Essex or the Group, HKG: 1061) is pleased to announce that a Biologics License Application (BLA) for EB12-20145P (HLX04-O), a recombinant anti-VEGF humanized monoclonal antibody injection, has recently been accepted by the Centre for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China. The product is jointly developed by the Group and Shanghai Henlius Biotech, Inc. (Henlius, HKG: 2696) for the treatment of wet age-related macular degeneration (wet-AMD) in China.
The phase 3 clinical trial of EB12-20145P (HLX04-O) among Chinese patients (“AURA-1”) has successfully reached the primary endpoint in April this year. AURA-1 is a multi-centre, randomised, double-blind, active-controlled, and non-inferiority phase 3 clinical trial which aimed to compare the efficacy and safety of EB12-20145P (HLX04-O) with that of ranibizumab administered by intravitreal injection (“IVT”) in newly diagnosed wet-AMD patients.
In addition to AURA-1, the BLA of which has been validated by the NMPA, an international, multi-centre phase 3 clinical study of EB12-20145P (HLX04-O) in patients with wet-AMD is ongoing successively in several European countries, Australia, the United States, and China (“AURA-2”) with last patient last visit completed by January 2025. Moving forward, Essex will continue to strive for excellence by embracing innovation to develop first-in-class and best-in-class products, providing solutions for Tomorrow’s healthcare problems, Today.
About wet-AMD Age-related macular degeneration (“AMD”) is one of the leading causes of visual impairment and blindness in the elderly worldwide [1]. According to the World Health Organization (WHO), about 30 million people have suffered from AMD globally, and about half a million people become blind due to AMD each year [2]. Wet age-related macular degeneration (“wet-AMD”) is characterised by the formation of subretinal choroidal neovascularization (CNV) and is responsible for approximately 90% of cases of AMD-related blindness. Due to an aging population, wet-AMD has become a serious social medical problem and indicated a huge burden of unmet need [3]. With the development of treatment for fundus diseases, anti-VEGF drugs are becoming the first-line therapy for the management of wet-AMD [4], and the efficacy and safety of vitreous injection of bevacizumab for wet-AMD have been verified in multiple clinical studies [5-11].
About Essex Essex is a bio-pharmaceutical company that develops, manufactures, and commercialises genetically engineered therapeutic b-bFGF, with six commercialised biologics currently marketed in China. Additionally, the Company has a diverse portfolio of commercialised preservative-free unit-dose eye drops, Shilishun (Iodized Lecithin Capsules) and others, which are principally prescribed for wound healing and diseases in Ophthalmology and Dermatology.
These products are marketed and sold through approximately 14,000 hospitals, supported by the Company’s 44 regional offices in China. Leveraging its in-house R&D platform in growth factor and antibody technology, Essex maintains a robust pipeline of projects in various clinical stages, covering a wide range of fields and indications.
Reference [1] 2020(1). [2] Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004 Nov;82(11):844-51. [3] Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2): e106-116. [4] Li X R, Liu J P. Recognition of anti-VEGF therapy base on the mechanism of VEGF in wet age-related macular degeneration[J]. Zhonghua Shiyan Yanke Zazhi/Chinese Journal of Experimental Ophthalmology, 2012, 30(4):289-292. [5] Tufail A, Patel PJ, Egan C, Hykin P, da Cruz L, Gregor Z, Dowler J, Majid MA, Bailey C, Mohamed Q, Johnston R, Bunce C, Xing W; ABC Trial Investigators. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multi-centre randomized double masked study. BMJ. 2010 Jun 9;340:c2459. [6] Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011 May 19;364(20):1897-908. [7] Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S, Reeves BC. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology. 2012 Jul;119(7):1399-411. [8] Kodjikian L, Souied EH, Mimoun G, Mauget-Faÿsse M, Behar -Cohen F, Decullier E, Huot L, Aulagner G; GEFAL Study Group. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Ophthalmology. 2013 Nov;120(11):2300-9. [9] Krebs I, Schmetterer L, Boltz A, Told R, Vécsei-Marlovits V, Egger S, Schönherr U, Haas A, Ansari-Shahrezaei S, Binder S; MANTA Research Group. A randomized double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration. Br J Ophthalmol. 2013 Mar;97(3):266-71. [10] Berg K, Pedersen TR, Sandvik L, Bragadóttir R. Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol. Ophthalmology. 2015 Jan;122(1):146-52. [11] Schauwvlieghe AM, Dijkman G, Hooymans JM, Verbraak FD, Hoyng CB, Dijkgraaf MG, Peto T, Vingerling JR, Schlingemann RO. Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study. PLoS One. 2016 May 20;11(5): e0153052.
